A Phase II Study of Paclitaxel and Carboplatin in Patients With an Elevated-Risk Cancer of the Uterus

NCT00584909 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped low accrual

Conditions

Uterine Cancer

Interventions

DRUG: Paclitaxel and carboplatin combination

Sponsor

University of Alabama at Birmingham